InvestmentMay 22, 2026, 05:22 PM
Anteris Technologies to Offer Up to $250M in Common Stock via ATM
AI Summary
Anteris Technologies Global Corp. has entered into a Sales Agreement with TD Securities (USA) LLC to establish an "at the market" offering program. Under this agreement, the company may offer and sell up to $250,000,000 of its common stock from time to time. TD Cowen will act as the sales agent, receiving a commission of 3.0% of the gross proceeds from sales. The net proceeds from this offering are primarily designated for the ongoing development of the DurAVR® Transcatheter Heart Valve System, with the remainder allocated to working capital and general corporate purposes.
Key Highlights
- Anteris Technologies entered a Sales Agreement with TD Securities (USA) LLC for an "at the market" offering.
- The company may offer and sell up to $250,000,000 of its common stock through TD Cowen.
- TD Cowen will act as agent and/or principal, using commercially reasonable efforts to sell the common stock.
- The commission payable to TD Cowen for sales as agent will be 3.0% of the gross proceeds.
- Net proceeds are intended primarily for the ongoing development of the DurAVR® Transcatheter Heart Valve System.
- Remaining proceeds will be used for working capital and other general corporate purposes.
- The offering will terminate upon the sale of all shares or termination of the agreement by either party with ten days' notice.
Price Impact
More from AVR